首页 | 本学科首页   官方微博 | 高级检索  
检索        

疏肝消脂方治疗非酒精性脂肪肝31例
引用本文:王玉晓,朱平生.疏肝消脂方治疗非酒精性脂肪肝31例[J].河南中医,2016(5):815-817.
作者姓名:王玉晓  朱平生
作者单位:1. 平顶山市第二人民医院,河南平顶山,467000;2. 河南中医学院,河南郑州,450046
基金项目:2015年度河南省科技创新人才计划-杰出青年基金(编号:154100510020)
摘    要:目的:观察疏肝消脂方治疗非酒精性脂肪肝的临床疗效。方法:将62例非酒精性脂肪肝患者随机分为对照组和治疗组各31例,对照组采用多烯磷脂酰胆碱胶囊和非诺贝特治疗,治疗组在对照组治疗的基础上加用疏肝消脂方治疗,观察两组患者临床疗效、肝功能及血脂指标。结果:对照组有效率为71.0%,治疗组有效率为90.3%,两组有效率比较,差异有显著性(P0.05);两组患者治疗后ALT、AST、TC、TG均显著降低(P0.01);且治疗组在降低TG,TC方面优于对照组(P0.05)。结论:疏肝消脂方治疗非酒精性脂肪肝疗效显著。

关 键 词:非酒精性脂肪肝  疏肝消脂方  多烯磷脂酰胆碱胶囊  非诺贝特片

Thirty-One Cases with Non-Alcoholic Fatty Liver Disease Treated with Liver-Dispersing and Fat-Resolving Formula
Abstract:Objective:To observe the clinical effects of Liver-Dispersing and Fat-Resolving Formula on non-alcoholic fatty liver disease (NAFLD).Methods:Totally 62 patients with NAFLD were randomly divided into control group and treatment group,with 31 cases in each group.Control group were given Polyene Phosphatidylcholine Capsules and Fenofibrate for the treatment while treatment group were additionally given Liver-Dispersing and Fat-Resolving Formula for the treatment.The clinical effects,liver function and blood lipid index in the two groups were observed,Results:The effective rate was 71.0% in control group and 90.3% in treatment group;the difference had statistical significance (P <0.05).The levels of ALT,AST,TG and TC in both groups got significantly decline in both groups (P < 0.01).And the decline of the levels of TG and TC in treatment group were better than that in control group (P <0.05).Conclusion:Liver-Dispersing and Fat-Resolving Formula has remarkable therapeutic effects on NAFLD.
Keywords:NAFLD  Liver-Dispersing and Fat-Resolving Formula  Polyene Phosphatidylcholine Capsules  Fenofibrate
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号